AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2020
Mar 4, 2020
30237_dirs_2020-03-04_f7d84506-f18d-488b-9be9-ce0518c43e13.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-03-02
Reporting Person: Summy Amy B. (EVP, Chief Marketing Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-03-02 | Restricted Stock Unit | $ | A | 800 | Acquired | Common Stock (800) | Direct | |
| 2020-03-02 | Restricted Stock Unit | $ | A | 1340 | Acquired | Common Stock (1340) | Direct | |
| 2020-03-02 | Non-qualified Stock Options | $187.96 | A | 3600 | Acquired | 2030-02-03 | Common Stock (3600) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vest in three equal annual installments beginning on February 4, 2021.
F3: The Restricted Stock Units fully vest on March 2, 2023.
F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F5: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F6: The option vests in three equal annual installments beginning on the date reflected in this column.